Locally advanced gastric cancer treated with neoadjuvant chemotherapy: Epirubicin, oxaliplatin, and capecitabine (EOX)

被引：0
|
作者：
Pluschnig, U. [1 ]
Zacherl, J. [1 ]
Schoppmann, S. [1 ]
Raderer, M. [1 ]
Prager, G. [1 ]
Bartsch, R. [1 ]
Ba-Ssalamah, A. [1 ]
Lamm, W. [1 ]
Zielinski, C. [1 ]
Hejna, M. [1 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
136
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant chemotheraphy in locally advanced gastric cancer with epirubicin, oxaliplatin, and capecitabine (EOX): A retrospective analysis
    Pluschnig, U.
    Zacherl, J.
    Schoppmann, S.
    Raderer, M.
    Prager, G.
    Bartsch, R.
    Ba-Ssalamah, A.
    Lamm, W.
    Zielinski, C.
    Hejna, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Neoadjuvant epirubicin, oxaliplatin and capecitabine (EOX) in locally advanced resectable gastroesophageal junction and gastric adenocarcinoma: the experience in our institution
    Martinez, J.
    Limon, M.
    Sanchez, I.
    Falcon, A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 24 - 24
  • [3] Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX)
    Wang, Yan
    Zhuang, Rong-yuan
    Yu, Yi-yi
    Yu, Shan
    Hou, Jun
    Ji, Yuan
    Sun, Yi-hong
    Shen, Kun-tang
    Shen, Zhen-bin
    Liu, Feng-lin
    Zhao, Nai-qing
    Liu, Tian-shu
    [J]. ONCOTARGET, 2016, 7 (46) : 76298 - 76307
  • [4] Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: Capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX)
    Wang, Yan
    Yu, Yiyi
    Zhuang, Rongyuan
    Yu, Shan
    Hou, Jun
    Ji, Yuan
    Sun, Yihong
    Shen, Kuntang
    Shen, Zhenbin
    Liu, Fenglin
    Zhao, Naiqing
    Liu, Tianshu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer
    Satake, Hironaga
    Kondo, Masato
    Mizumoto, Motoko
    Kotake, Takeshi
    Okita, Yoshihiro
    Ogata, Takatsugu
    Hatachi, Yukimasa
    Yasui, Hisateru
    Miki, Akira
    Imai, Yukihiro
    Ichikawa, Chihiro
    Murotani, Kenta
    Kotaka, Masahito
    Kato, Takeshi
    Kaihara, Satoshi
    Tsuji, Akihito
    [J]. ANTICANCER RESEARCH, 2017, 37 (07) : 3703 - 3710
  • [6] Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis
    Ostwal, Vikas
    Sahu, Arvind
    Ramaswamy, Anant
    Sirohi, Bhawna
    Bose, Subhadeep
    Talreja, Vikas
    Goel, Mahesh
    Patkar, Shraddha
    Desouza, Ashwin
    Shrikhande, Shailesh V.
    [J]. JOURNAL OF GASTRIC CANCER, 2017, 17 (01) : 21 - 32
  • [7] A restrospective analysis of toxicities encountered with palliative epirubicin, oxaliplatin, and capecitabine (EOX) chemotherapy for advanced esophagogastric cancer.
    Khakoo, Shelize Sadrudin
    Georgiou, Alexandros
    Waters, Justin S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [8] A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial
    Gerardo Rosati
    Chiara Alessandra Cella
    Luigi Cavanna
    Carla Codecà
    Michele Prisciandaro
    Stefania Mosconi
    Giovanna Luchena
    Nicola Silvestris
    Ilaria Bernardini
    Rossana Casaretti
    Federica Zoratto
    Domenico Amoroso
    Andrea Ciarlo
    Sandro Barni
    Stefano Cascinu
    Cristina Davite
    Alessandro Di Sanzo
    Alessia Casolaro
    Domenico Bilancia
    Roberto Labianca
    [J]. Gastric Cancer, 2022, 25 : 783 - 793
  • [9] A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial
    Rosati, Gerardo
    Cella, Chiara Alessandra
    Cavanna, Luigi
    Codeca, Carla
    Prisciandaro, Michele
    Mosconi, Stefania
    Luchena, Giovanna
    Silvestris, Nicola
    Bernardini, Ilaria
    Casaretti, Rossana
    Zoratto, Federica
    Amoroso, Domenico
    Ciarlo, Andrea
    Barni, Sandro
    Cascinu, Stefano
    Davite, Cristina
    Di Sanzo, Alessandro
    Casolaro, Alessia
    Bilancia, Domenico
    Labianca, Roberto
    [J]. GASTRIC CANCER, 2022, 25 (04) : 783 - 793
  • [10] Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery
    A. M. Mongan
    R. Kalachand
    S. King
    N. J. O’Farrell
    D. Power
    N. Ravi
    C. Muldoon
    K. O’Byrne
    J. V. Reynolds
    [J]. Irish Journal of Medical Science (1971 -), 2015, 184 : 417 - 423
12345